Pharmasys Private Limited
About Pharmasys Private Limited
Data last updated:
Pharmasys Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2019PTC350978. Its GSTIN is 07AAKCP5928K1ZV (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Amit Mediratta and Anil Mediratta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 6 1st Floor Lsc Pocket – 5 Sector A – 10 Opp. Sports Complex Narela, Delhi, India – 110040.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.46 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹3.62 Cr (net margin 23.4%) and EBITDA of ₹5.18 Cr (EBITDA margin 33.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 54% over five years.
As per MCA filings, the company has open charges of ₹4.29 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No – 6 1st Floor Lsc Pocket – 5 Sector A – 10 Opp. Sports Complex Narela, Delhi, India – 110040
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pharmasys Private Limited
The main business activities of Pharmasys are trade and manufacturing. In detail, this covers wholesale trading and other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pharmasys Private Limited FY 2025 filings available
Pharmasys Private Limited reported revenue of ₹15.46 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Pharmasys Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 5% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharmasys Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.18 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.62 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharmasys Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 23.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pharmasys are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pharmasys Private Limited
Pharmasys Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tosc International Private Limited | ₹15.49 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Delhi, India |
| Lia Life Sciences Private Limited | ₹15.49 Cr (FY 2022) | •••• | •••• | 19.0% | •••• | Chennai, Tamil Nadu, India |
| Argos International Marketing Private Limited | ₹15.48 Cr (FY 2025) | •••• | •••• | 221.0% | •••• | Mumbai, Maharashtra, India |
| R P Biotech Private Limited | ₹15.48 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Gurdaspur, Punjab, India |
| Geomedics Pharma Private Limited | ₹15.47 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Pune, Maharashtra, India |
| Pharmasys Private Limited this company | ₹15.46 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Delhi, India |
| Sifam Healthcare Private Limited | ₹15.43 Cr (FY 2022) | •••• | •••• | -6.0% | •••• | Ahmedabad, Gujarat, India |
| Shri Bhagatji Surgicals Private Limited | ₹15.41 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Dadri, Uttar Pradesh, India |
| Mitoch Pharma Private Limited | ₹15.39 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Ishita Drugs and Industries Limited Listed | ₹15.33 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Nuclotec Remedies Private Limited | ₹15.32 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Pharmasys by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pharmasys Private Limited
Pharmasys Private Limited is audited by AHMAD SHUKLA JAIN AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AHMAD SHUKLA JAIN AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pharmasys Private Limited
Pharmasys has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Mediratta Also directs: Veritas Life Sciences Limited, Generica India Limited | Director | 06 Jun 2019 | 7 Years 4 Months | Current |
| Anil Mediratta | Director | 06 Jun 2019 | 7 Years 4 Months | Current |
Ownership and Shareholding of Pharmasys Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharmasys Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2024 | Indian Bank | ₹4.29 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Pharmasys Private Limited
Employment history and EPFO contributions of people linked to Pharmasys.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharmasys Private Limited
Pharmasys Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Amit Mediratta was appointed as Director on 06 Jun 2019.
Credit Ratings, Litigation & Regulatory Alerts for Pharmasys Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmasys Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmasys Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharmasys Private Limited
Pharmasys has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCP5928K1ZV | Delhi | Active | 13 Sep 2019 |
| 07AAKCP5928K2ZU | Delhi | Active | 10 Jun 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmasys Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmasys Private Limited
Pharmasys is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 June 2019 (7+ years old) and is registered under CIN U24304DL2019PTC350978.
Pharmasys reported revenue of ₹15.46 Cr for FY 2025 (up 5% YoY).
Pharmasys has 2 current directors:
- Amit Mediratta - Director
- Anil Mediratta - Director
Pharmasys reported a net profit of ₹3.62 Cr (net margin 23.4%) and EBITDA of ₹5.18 Cr (EBITDA margin 33.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharmasys is -11% over three years and 54% over five years. In the latest year (FY 2025) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pharmasys is 07AAKCP5928K1ZV, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AAKCP5928K2ZU (Delhi).
The CIN (Corporate Identification Number) of Pharmasys is U24304DL2019PTC350978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmasys was incorporated on 06 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Pharmasys by revenue are Tosc International Private Limited, Lia Life Sciences Private Limited, Argos International Marketing Private Limited, R P Biotech Private Limited, Geomedics Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Amit Mediratta was appointed as Director on 06 Jun 2019. Anil Mediratta was appointed as Director on 06 Jun 2019.
The registered office of Pharmasys is at Plot No – 6 1st Floor Lsc Pocket – 5 Sector A – 10 Opp. Sports Complex Narela, Delhi, India – 110040.